Search Orphan Drug Designations and Approvals
-
Generic Name: | Paxalisib |
---|---|
Date Designated: | 08/21/2020 |
Orphan Designation: | Treatment of malignant glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Kazia Therapeutics Limited ACN 063 259 754 Level 24, 300 Barangaroo Avenue Sydney, NSW 2000 Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-